Technical Analysis for N4P - N4 Pharma Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jack-in-the-Box Bullish | Bullish Swing Setup | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Crossed Above 50 DMA | Bullish | -2.94% | |
| MACD Bullish Centerline Cross | Bullish | -2.94% | |
| Expansion Breakout | Bullish Swing Setup | -2.94% | |
| Expansion Pivot Buy Setup | Bullish Swing Setup | -2.94% | |
| Pocket Pivot | Bullish Swing Setup | -2.94% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 4 hours ago |
| 1.5x Volume Pace | about 4 hours ago |
| Possible Inside Day | about 5 hours ago |
| Gap Down Closed | about 8 hours ago |
| Gap Down Partially Closed | about 8 hours ago |
Get this analysis on your stocks daily!
N4 Pharma Plc Description
N4 Pharma Plc, a specialist pharmaceutical company, develops and licenses novel therapeutic products pharmaceutical and biotechnology companies in the United Kingdom. It reformulates marketed generic drugs; and improves delivery of novel and existing vaccines and therapeutics. The company is developing Sildenafil for use in treating erectile dysfunction; Sartans for the treatment of hypertension; Aprepitant for use in oncology and pain relief; and Aprepitant for the treatment of premature ejaculation. It is also developing Nuvec, an engineered silica nanoparticle for use in intracellular delivery of large nucleic acids, such as pDNA and mRNA; and Single dose Hepatitis B vaccine. The company has a research collaboration with MedImmune to explore the manufacture of a prototype nanomedicine using its Nuvec system; and Nanomerics Limited to produce and test two candidate formulations using the Nuvec delivery system. N4 Pharma Plc is based in London, the United Kingdom.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Biotechnology Pain Pharmaceutical Medicine Drugs Oncology Mr Vaccine Astrazeneca Biotechnology Companies Acell Organic Compounds Therapeutic Products Aprepitant Chemical Compounds Erectile Dysfunction Hepatitis Lactams Nanomedicine Nanoparticle
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.2899 |
| 52 Week Low | 0.6 |
| Average Volume | 707,029 |
| 200-Day Moving Average | 1.05 |
| 50-Day Moving Average | 0.74 |
| 20-Day Moving Average | 0.72 |
| 10-Day Moving Average | 0.75 |
| Average True Range | 0.06 |
| RSI (14) | 63.50 |
| ADX | 20.1 |
| +DI | 26.49 |
| -DI | 8.12 |
| Chandelier Exit (Long, 3 ATRs) | 0.71 |
| Chandelier Exit (Short, 3 ATRs) | 0.79 |
| Upper Bollinger Bands | 0.82 |
| Lower Bollinger Band | 0.63 |
| Percent B (%b) | 1.02 |
| BandWidth | 27.16 |
| MACD Line | 0.01 |
| MACD Signal Line | -0.01 |
| MACD Histogram | 0.0163 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.89 | ||||
| Resistance 3 (R3) | 0.88 | 0.86 | 0.88 | ||
| Resistance 2 (R2) | 0.86 | 0.85 | 0.86 | 0.87 | |
| Resistance 1 (R1) | 0.84 | 0.84 | 0.83 | 0.85 | 0.87 |
| Pivot Point | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 |
| Support 1 (S1) | 0.80 | 0.81 | 0.79 | 0.81 | 0.78 |
| Support 2 (S2) | 0.78 | 0.80 | 0.78 | 0.78 | |
| Support 3 (S3) | 0.76 | 0.78 | 0.78 | ||
| Support 4 (S4) | 0.77 |
